The US Food and Drug Administration has completed its review of the investigational new drug application for MIN-202, Minerva Neurosciences Inc’s selective antagonist for the orexin-2 receptor in development for the...
Read MoreNovaDel Pharma Inc has sold its Zolpimist new drug application to Amherst Pharmaceuticals LLC. Zolpimist (zolpidem tartrate) is a patented, FDA approved bioequivalent version of sleep aid Ambien in an oral spray formulation. The...
Read More
Project Sleep’s new infographic shines highlights how sleep works in our favor during the day. Get...
Read More
Like more than 20 million other Americans, John Brugger has been diagnosed with sleep apnea. He...
Read MoreSensory Medical Inc, the creator of the Relaxis device for restless leg syndrome (RLS), has appointed David Baker as its president and CEO. A seasoned medical technology executive with more than two decades of experience in the...
Read More